Pharma’s most underestimated cyber risk isn’t a breach
Pharma’s most underestimated cyber risk isn’t a breach 2026-01-05 at 08:47 By Mirko Zorz Chirag Shah, Global Information Security Officer & DPO at Model N examines how cyber risk in pharma and life sciences is shifting beyond traditional breaches toward data misuse, AI-driven exposure and regulatory pressure. He explains why executives still underestimate silent control […]
Pharma’s most underestimated cyber risk isn’t a breach Read More »